Oruka Therapeutics (ORKA) Misses Q2 EPS by 4c
Get Alerts ORKA Hot Sheet
Join SI Premium – FREE
Oruka Therapeutics (NASDAQ: ORKA) reported Q2 EPS of ($0.55), $0.04 worse than the analyst estimate of ($0.51).
For earnings history and earnings-related data on Oruka Therapeutics (ORKA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dyadic International, Inc. (DYAI) Misses Q2 EPS by 2c
- Sea Ltd. (SE) PT Raised to $175 at Benchmark on Robust Growth
- WhiteFiber, Inc. (WYFI) Misses Q2 EPS by 36c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share